Abstract:Objective and design Tumor necrosis factor-α (TNF-α) is a proinflammatory cytokine that induces apoptosis in a number of cell systems, including osteoblasts. Simvastatin is a potent 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor known as a stimulator for bone formation via promoting osteoblast differentiation and mineralization. This study was designed to examine the role of simvastatin on TNF-α-induced growth inhibition and apoptosis in murine osteoblastic MC3T3-E1 cells. Materials and methods MC3T3-E1 cells were cultured in DMEM essential medium supplemented with 10% fetal bovine serum and antibiotics, and 3-(4,5-dimethylthiazol-2yl-)-2,5-diphenyl tetrazolium bromide (MTT) assay was used to evaluate cell viability. A trypan blue exclusion assay was used to determine the level of cytotoxicity. Hoechst staining for cells treated with TNF-α was visualized under a microscope equipped with an epifluorescence illumination. Apoptosis of MC3T3-E1 cells was further examined by flow cytometric analysis after Annexin V/7-AAD double staining. Results MC3T3-E1 cells exposed to low concentrations (10 −10 –10 −7 M) of simvastatin increased in both growth and viability. In contrast, high concentrations of simvastatin (10 −6 –10 −5 M) have no effect on growth and viability of MC3T3-E1 cells. TNF-α-induced decrease in cell viability and growth were antagonized by simvastatin in a concentration-dependent manner. MC3T3-E1 cells treated with TNF-α at 10 ng/ml showed typical pyknotic fragmented nuclei and apoptotic bodies assessed by Hoechst staining. Moreover, Annexin V/7-AAD double staining indicated that MC3T3-E1 cells treated with 10 ng/ml of TNF-α resulted in a significant increase of the proportion of apoptotic cells up to 39.5% of total cell population, and the proportion of apoptotic cells were dose-dependently decreased after simvastatin treatment (10 −10 – 10 −7 M); the inhibitory rates were approximately 31.34, 48.5, 52.11, and 65.73%, respectively. Conclusions Our data demonstrate that simvastatin increases growth and viability of osteoblastic cells and decreases TNF-α-induced growth inhibition and apoptosis in murine osteoblastic MC3T3-E1 cells.

Simvastatin potently induces calcium-dependent apoptosis of human leiomyoma cells

Statins enhance anti-tumro effect of sub reoylanilide hydroxamic acid on human non-small cell lung carcinoma cells

Simvastatin Protects Human Osteosarcoma Cells from Oxidative Stress-Induced Apoptosis Through Mitochondrial-Mediated Signaling

Apoptosis induced by simvastatin in rat vascular smooth muscle cell through Ca2+-calpain and caspase-3 dependent pathway.

Simvastatin reduces plasma membrane caveolae and caveolin-1 in uterine leiomyomas

Simvastatin, at clinically relevant concentrations, affects human uterine leiomyoma growth and extracellular matrix production

Simvastatin induces breast cancer cell death through oxidative stress up-regulating miR-140-5p

Apoptosis Induced by Simvastatin in Rat Vascular Smooth Muscle Cells Through Calpain and Caspase-3-dependent Pathways

Statins induce apoptosis through inhibition of Ras signaling pathways and enhancement of Bim and p27 expression in human hematopoietic tumor cells

Activation of C-Jun N-Terminal Kinase is Required for Mevastatin-Induced Apoptosis of Salivary Adenoid Cystic Carcinoma Cells

Simvastatin attenuates TNF-α-induced growth inhibition and apoptosis in murine osteoblastic MC3T3-E1 cells

Statins decrease the expression of c-Myc protein in cancer cell lines

Effect of Statin Lipophilicity on the Proliferation of Hepatocellular Carcinoma Cells

Simvastatin-loaded liposome nanoparticles treatment for uterine leiomyoma in a patient-derived xenograft mouse model: a pilot study

Inhibition of Proliferation and Induction of Apoptosis by Simvastatin in K562 Le Ukemic Cell Line

Effects of Lipophilic Statins on Cell Viability and Tissue Factor Expression in Canine Haemangiosarcoma Cells

The Effect of Statins on Markers of Breast Cancer Proliferation and Apoptosis in Women with In Situ or Early-Stage Invasive Breast Cancer

Simvastatin induces pyroptosis via ROS/caspase-1/GSDMD pathway in colon cancer

Synergistic effect of receptor-interacting protein 140 and simvastatin on the inhibition of proliferation and survival of hepatocellular carcinoma cells

Simvastatin Suppresses the Proangiogenic Microenvironment of Human Hepatic Stellate Cells Via the Kruppel-like Factor 2 Pathway.

Simvastatin enhances radiation sensitivity of colorectal cancer cells